ARMOUR's DDAVP NASAL SPRAY FOR MILD HEMOPHILIA A AND VON WILLEBRAND's
Executive Summary
ARMOUR's DDAVP NASAL SPRAY FOR MILD HEMOPHILIA A AND VON WILLEBRAND's disease will be available in the late second or early third quarter, the company said. Desmopressin acetate 1.5 mg/ml will be marketed by the Rhone-Poulenc Rorer unit in a 5 ml spray pump bottle delivering 25 single administrations of 150 mcgs of DDAVP.